Healthy adults
Conditions
Interventions
Ingest of probiotic food during the 4-week intervention period
Sponsors
TOTO LTD. Research Institute
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Those whose workplace is the TOTO Research Institute on the date of consent 2.Those who have received sufficient explanation about the purpose and content of this study, have the ability to consent, fully volunteered with voluntary intention, agreed to participate
Exclusion criteria
Exclusion criteria: 1.Those who regularly use medicines that affect the intestinal environment, such as Intestinal regulator, constipation medicine, laxative. 2.Those who cannot stop taking foods for specified health uses, foods with functional claims, health foods, or foods containing lactobacillus, bifidobacterium, oligosaccharides, etc. during the study period. 3.Those who have a disease of the liver, kidneys, heart, lungs, digestive system, blood, endocrine system, or metabolism, or those who have a serious medical history of such diseases. 4.Those who have a serious drug or food allergy or a history of serious allergies. 5.Those who have a milk allergy or lactose intolerance. 6.Those who are pregnant, intend to become pregnant during the study period, or are breastfeeding. 7.Those who have participated in other drug or food trials within the past month, or those who intend to participate in such trials during the study. 8.Those who are deemed unsuitable as subjects by the study physician based on the results of the subject background, etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Defecation-related indicator | — |
Countries
Japan
Contacts
Public ContactAyano Hosokawa
TOTO LTD. Research Institute Life Science R&D Dept
Outcome results
None listed